Pharmaceutical Standards
Pharmaceutical standards are a comprehensive set of reference materials essential for ensuring the safety, efficacy, and quality of pharmaceutical products. This category includes standards for active pharmaceutical ingredients (APIs), which are the core components responsible for therapeutic effects. Additionally, it covers compounds and metabolites relevant to both the pharmaceutical and veterinary industries, providing benchmarks for the accurate measurement and analysis of these substances. Nitrosamine control standards are crucial for detecting and mitigating potentially harmful nitrosamines in drug formulations. Toxicology standards help assess the safety and potential adverse effects of pharmaceutical compounds. Furthermore, enzyme activators and inhibitors standards are vital for research and development, enabling precise studies of biochemical pathways and drug mechanisms. These pharmaceutical standards are indispensable tools for regulatory compliance, quality control, and research, ensuring that pharmaceutical products meet stringent safety and effectiveness criteria.
Subcategories of "Pharmaceutical Standards"
Products of "Pharmaceutical Standards"
Zafirlukast related compound D
Ref: 3D-FZ63870
Undefined size | Discontinued | Request information |
3-Bromo-1,8-naphthyridine
Ref: 3D-FB152669
Undefined size | Discontinued | Request information |
Bufalin PEG3-Biotin
Ref: 3D-FB137445
Undefined size | Discontinued | Request information |
Phosphaoseltamivir, biotin conjugate
Ref: 3D-FP157343
Undefined size | Discontinued | Request information |
5'-Bromo-3,4'-dihexyl-2,2'-bithiophene
Ref: 3D-FB32492
Undefined size | Discontinued | Request information |
9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-(naphthalen-1-yl)purine
Ref: 3D-FD144919
Undefined size | Discontinued | Request information |
Difluoronitroacetic acid methyl ester
Ref: 3D-FD83349
Undefined size | Discontinued | Request information |
Revatropate
Ref: 3D-FR159755
Undefined size | Discontinued | Request information |
Tacrolimus hydroxy acid impurity
Ref: 3D-FT164197
Undefined size | Discontinued | Request information |
1,N6-Etheno-ara-adenosine
Ref: 3D-FE144940
Undefined size | Discontinued | Request information |
N4-Boc-5-iodocytosin-1-yl-acetic acid
Ref: 3D-FB144908
Undefined size | Discontinued | Request information |
Micafungin impurity 4
Ref: 3D-FM159239
Undefined size | Discontinued | Request information |
4,4-Dimethyl retinoic acid
Ref: 3D-FD22256
Undefined size | Discontinued | Request information |
(2S)-2,7-Diamino-2,3-dihydro-1-hydroxy-9-hydroxymethyl-6-methyl-1H-pyrrolo[1,2-a]indole-5,8-dione labelled by biotin on 2 position
Ref: 3D-FD45125
Undefined size | Discontinued | Request information |
Astragalin 4',2'',3'',4'',6''-pentaacetate
Ref: 3D-FA39423
Undefined size | Discontinued | Request information |
6'-Hydroxy-7'-ethoxybergamottin
Ref: 3D-FH39431
Undefined size | Discontinued | Request information |
Oxaliplatin impurity B
Ref: 3D-FO63803
Undefined size | Discontinued | Request information |
Cefprozil related compound L
Ref: 3D-FC63709
Undefined size | Discontinued | Request information |
rac pterosin B
Ref: 3D-FR27569
Undefined size | Discontinued | Request information |
(S)-(-)-5,5'-Dichloro-6,6'-dimethoxy-2,2'-bis(diphenylphosphino)-1,1'-biphenyl
Ref: 3D-FD139074
Undefined size | Discontinued | Request information |